<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">medsovet</journal-id><journal-title-group><journal-title xml:lang="ru">Медицинский Совет</journal-title><trans-title-group xml:lang="en"><trans-title>Meditsinskiy sovet = Medical Council</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2079-701X</issn><issn pub-type="epub">2658-5790</issn><publisher><publisher-name>REMEDIUM GROUP Ltd.</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.21518/2079-701X-2017-20-157-159</article-id><article-id custom-type="elpub" pub-id-type="custom">medsovet-2247</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>Эндокринология</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>Endocrinology</subject></subj-group></article-categories><title-group><article-title>МЕТАБОЛИЧЕСКИЕ ОСОБЕННОСТИ ПАЦИЕНТОВ С ОЖИРЕНИЕМ</article-title><trans-title-group xml:lang="en"><trans-title>METABOLIC CHARACTERISTICS OF PATIENTS WITH OBESITY</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Бардымова</surname><given-names>Т. П.</given-names></name><name name-style="western" xml:lang="en"><surname>Bardymova</surname><given-names>T. P.</given-names></name></name-alternatives><bio xml:lang="ru"><p>доктор медицинских наук, профессор.</p><p>Иркутск.</p></bio><bio xml:lang="en"><p>MD, Prof.</p><p>Irkutsk. </p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Березина</surname><given-names>М. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Berezina</surname><given-names>M. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Иркутск.</p></bio><bio xml:lang="en"><p>Irkutsk.</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Батунова</surname><given-names>Е. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Batunova</surname><given-names>E. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Иркутск.</p></bio><bio xml:lang="en"><p>Irkutsk.</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Мирошниченко</surname><given-names>И. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Miroshnichenko</surname><given-names>I. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Иркутск.</p></bio><bio xml:lang="en"><p>Irkutsk.</p></bio><xref ref-type="aff" rid="aff-2"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>Иркутская государственная медицинская академия последипломного образования – филиал Российской медицинской академии непрерывного профессионального образования Минздрава России.</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Irkutsk State Medical Academy of Postgraduate Education – Branch Campus of the Federal State Budgetary Educational Institution of Further Professional Education «Russian Medical Academy of Continuing Professional Education» of the Ministry of Healthcare of the Russian Federation.</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru"><institution>Иркутский областной клинический консультативно-диагностический центр.</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Irkutsk Regional Clinical Consultative and Diagnostic Center.</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2017</year></pub-date><pub-date pub-type="epub"><day>07</day><month>01</month><year>2018</year></pub-date><volume>0</volume><issue>20</issue><fpage>157</fpage><lpage>159</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Бардымова Т.П., Березина М.В., Батунова Е.В., Мирошниченко И.А., 2018</copyright-statement><copyright-year>2018</copyright-year><copyright-holder xml:lang="ru">Бардымова Т.П., Березина М.В., Батунова Е.В., Мирошниченко И.А.</copyright-holder><copyright-holder xml:lang="en">Bardymova T.P., Berezina M.V., Batunova E.V., Miroshnichenko I.A.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.med-sovet.pro/jour/article/view/2247">https://www.med-sovet.pro/jour/article/view/2247</self-uri><abstract><p>Обоснование: Ожирение является одним из самых распространенных заболеваний в мире [<xref ref-type="bibr" rid="cit1">1</xref>]. Обладая гормональной активностью, жировая ткань участвует в координации процессов метаболизма. При ее избыточном накоплении неизменно нарушается протекание обменных процессов в самых различных органах и тканях [<xref ref-type="bibr" rid="cit2">2</xref>]. Цель работы: провести анализ метаболизма гормонов жировой ткани у пациентов с ожирением. Методы: обследовано 30 пациентов с ожирением без сопутствующей патологии. Определялись уровни адипокинов (лептина, адипонектина, висфатина), инсулина с расчетом индекса инсулинорезистентности (HOMA-IR), липидный спектр. Результаты: проведенный анализ показал, что в группе пациентов с ожирением установлено повышение показателей инсулина, лептина по сравнению с группой контроля. В свою очередь, уровень адипонектина в контрольной группе достоверно превышал аналогичный показатель у пациентов с ожирением. Существенных различий в показателях висфатина по сравнению с контрольной группой не зафиксировано. Параллельно с повышением лептина у пациентов с ожирением наблюдались гиперинсулинемия и дислипидемия (повышение холестерина липопротеидов низкой плотности (ХС-ЛПНП), триглицеридов (ТГ), снижение холестерина липопротеидов высокой плотности (ХС- ЛПВП)). Заключение: у пациентов с ожирением без соматической патологии установлены разнонаправленные изменения гормонов жировой ткани по сравнению с группой без ожирения и избыточного веса. Отмеченная динамика адипокинов способствует изменению функционирования физиологических систем организма и требует поиска наиболее информативных методов диагностики и эффективных методов коррекции.</p></abstract><trans-abstract xml:lang="en"><p>Background: Obesity is considered to be the most wide-spared disease all over the world [<xref ref-type="bibr" rid="cit1">1</xref>]. Having a hormonal activity, adipose tissue takes part in coordinating of metabolic processes. Taking into consideration the excess accumulation of the adipose tissue, the proceeding of metabolic process gets abidingly broken [<xref ref-type="bibr" rid="cit2">2</xref>]. Aims: The aim of this thesis is to analyze a hormone metabolism of the hormones of adipose tissue among the patients who has obesity. Materials and methods: 30 patients with obesity without any accompanying disease were examined. This examination was done to determine the level of adipokines (leptin, adiponectin, visfatin), insulin with index calculus of insulin resistance, blood lipids. Results: The analysis showed the fact that patients with obesity have a higher level of insulin, leptin in comparison to the control group. However, the level of adiponectin among people from the control group increased the same level of patients with obesity. The essential differences in the level of visfatin has not been discovered. Hyperinsulinemia and Dyslipidemia (increased cholesterol low density lipoprotein (TC-LDL), triglycerides (TG), reduction of cholesterol of high density lipoproteins (HDL – C)) are observed alongside the increase of leptin level among the patients with obesity. Conclusion: Multidirectional changes of hormones of adipose tissue are established among the patients with obesity without somatic pathology in comparison with the ones without obesity and overweight. The determined dynamics of adipokines contributes changes of functioning of physiological systems of out organism and demands the research of more informative and essential methods of correction.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>ожирение</kwd><kwd>адипокины</kwd><kwd>лептин</kwd><kwd>адипонектин</kwd><kwd>висфатин</kwd></kwd-group><kwd-group xml:lang="en"><kwd>оbesity</kwd><kwd>adipokines</kwd><kwd>leptin</kwd><kwd>adiponectin</kwd><kwd>visfatin</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">World Health Organization. DOI: http://www.who.int/mediacentre/ factsheets/fs311/ru/ (дата обращения: 20.10.2017).</mixed-citation><mixed-citation xml:lang="en">World Health Organization. DOI: http://www.who.int/mediacentre/ factsheets/fs311/ru/ (дата обращения: 20.10.2017).</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Кроненберг Г.М., Мелмед Ш., Полонски К.С., Ларсен П.Р. Ожирение и нарушения липидного обмена. Пер. с англ. М.: Рид Элсивер, 2010, 264 с.</mixed-citation><mixed-citation xml:lang="en">Кроненберг Г.М., Мелмед Ш., Полонски К.С., Ларсен П.Р. Ожирение и нарушения липидного обмена. Пер. с англ. М.: Рид Элсивер, 2010, 264 с.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Rasouli N, Kern PA. Adipocytokines and the Metabolic Complications of Obesity. The Journal of Clinical Endocrinology &amp; Metabolism, 2008, 93(11_supplement_1): 64-73. DOI: 10.1210/jc.2008-1613.</mixed-citation><mixed-citation xml:lang="en">Rasouli N, Kern PA. Adipocytokines and the Metabolic Complications of Obesity. The Journal of Clinical Endocrinology &amp; Metabolism, 2008, 93(11_supplement_1): 64-73. DOI: 10.1210/jc.2008-1613.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Косыгина А.В. Адипоцитокины в научной и клинической практике. Ожирение и метаболизм, 2011, 1(26): 32-39.</mixed-citation><mixed-citation xml:lang="en">Косыгина А.В. Адипоцитокины в научной и клинической практике. Ожирение и метаболизм, 2011, 1(26): 32-39.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Yadav A, Kataria MA, Saini V. Role of leptin and adiponectin in insulin resistance. Clin. Chim. Acta, 2013, 417: 80-84.</mixed-citation><mixed-citation xml:lang="en">Yadav A, Kataria MA, Saini V. Role of leptin and adiponectin in insulin resistance. Clin. Chim. Acta, 2013, 417: 80-84.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Baratta R, Amato S, Degano C et al. Adiponectin relationship with lipid metabolism is independent of body fat mass: evidence from both cross-sectional and intervention studies. J. Clin. Endocrinol. Metab., 2004, 89: 2665-2671.</mixed-citation><mixed-citation xml:lang="en">Baratta R, Amato S, Degano C et al. Adiponectin relationship with lipid metabolism is independent of body fat mass: evidence from both cross-sectional and intervention studies. J. Clin. Endocrinol. Metab., 2004, 89: 2665-2671.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Fasshauer M, Blbher M. Adipokines in health and disease. Trends Pharmacol. Sci., 2015, 36(7): 461-470.</mixed-citation><mixed-citation xml:lang="en">Fasshauer M, Blbher M. Adipokines in health and disease. Trends Pharmacol. Sci., 2015, 36(7): 461-470.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Berndt J, Kloting N, Kralisch S et al. Plasma visfatin concentrations and fat depot-specific mRNA expression in humans. Diabetes, 205, 54: 2911-2916.</mixed-citation><mixed-citation xml:lang="en">Berndt J, Kloting N, Kralisch S et al. Plasma visfatin concentrations and fat depot-specific mRNA expression in humans. Diabetes, 205, 54: 2911-2916.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Fukuhara A, Matsuda M, Nishizawa M et al. (2005). Visfatin: a protein secreted by visceral fat that mimics the effects of insulin. Science, 2005, 307: 426-430.</mixed-citation><mixed-citation xml:lang="en">Fukuhara A, Matsuda M, Nishizawa M et al. (2005). Visfatin: a protein secreted by visceral fat that mimics the effects of insulin. Science, 2005, 307: 426-430.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
